References
The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
1 – Dimitrios Kapogiannis et al., The FASEB Journal 29, no. 2, 589–96, February 2015
Dysfunctionally Phosphorylated Type 1 Insulin Receptor Substrate in Neural-Derived Blood Exosomes of Preclinical Alzheimer’s Disease
2 – Suzanne M. de la Monte and Jack R. Wands, Journal of Diabetes Science and Technology 2, no. 6, 1101–13, November 2008
Alzheimer’s Disease Is Type 3 Diabetes – Evidence Reviewed
3 – Stephen C. Cunnane et al., Annals of the New York Academy of Sciences 1367, no. 1, January 2016
Can Ketones Compensate for Deteriorating Brain Glucose Uptake During Aging? Implications for the Risk and Treatment of Alzheimer’s Disease
4 – J. J. Sevigny et al., Neurology 71, no. 21, 1702–08, November 2008
Growth Hormone Secretagogue MK-677
5 – Sung-Wuk Jang et al., Proceedings of the National Academy of Sciences of the United States of America 107, no. 6, 2687–92, February 2010
A Selective TrkB Agonist with Potent Neurotrophic Activities by 7,8-Dihydroxyflavone
6 – Nian-Sheng Tzeng et al., Neurotherapeutics 15, no. 2, 417–29,, February 2018